pyrazines has been researched along with Carcinoma, Lewis Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, M; Childs, R; Lundqvist, A; Smith, A; Yokoyama, H | 1 |
| Elliott, PJ; Ross, JS | 1 |
1 review(s) available for pyrazines and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
The proteasome: a new target for novel drug therapies.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Carcinoma, Lewis Lung; Clinical Trials, Phase I as Topic; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Disease Models, Animal; Humans; Multienzyme Complexes; Neoplasms; Proteasome Endopeptidase Complex; Pyrazines | 2001 |
1 other study(ies) available for pyrazines and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells.
Topics: Adoptive Transfer; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Carcinoma, Lewis Lung; Caspase 8; Cell Proliferation; Granzymes; Humans; Kidney Neoplasms; Killer Cells, Natural; Lymphocyte Depletion; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pyrazines; T-Lymphocytes, Regulatory | 2009 |